Materials Science and Engineering

Nanobiotix

Nanobiotix is a nanomedicine company dedicated for the development of novel treatments and new therapeutics evolving based on the combined applications of nanotechnology and biotechnology for the local treatment of cancer. Nanobiotix researches and progresses biopharmaceutical medicine. Nanobiotix offers oncology nanomedicine treatments to control and treat cancer tumors. Bionanotechnology plays a critical role in both tissue engineering and drug delivery. Nanobiotix has improved a fresh class of therapeutics basing on nanoparticles and nanoxray therapeutics. They comprise of inert nanoparticles designed to enter in the tumor cells. They are injected straight through syringe into tumors, after stimulation by the standard dose of radiation, they relieve free radicals which destroys cancer cells. The lead product of the nanobiotix is NBTXR3 which is a radiosensitizer composed of hafnium oxide nanoparticles.